WASHINGTON, CT, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Evexia Diagnostics, a leading provider of ...

Clinical studies designed to support FDA clearance and planned commercial launch into the world’s largest drug screening market Company anticipates full data analysis by the end of March 2026; data to ...

SDPA releases its first Clinical Practice Guidelines on alopecia testing, advancing evidence-based care and strengthening the role of dermatology PAs. We hope these recommendations help streamline ...

As medicine advances toward more individualized care, clinical diagnostics are playing an increasingly vital role. Traditionally, diagnostic tests have been used to identify and classify diseases.

Expands range of applications for successful QIAcuity digital PCR platforms, now entering the clinical space across North America and the EU // Provides absolute quantitation, essential for precise ...

Patients reveal persistent gaps in genetic testing, diagnosis, and clinical trial access—and implications for advancing ...

Upheaval during the COVID pandemic has forced a rethinking of the steps to medical licensure, most recently clinical skills assessments. As a result, medical students across the nation will likely ...

Script Concordance Testing (SCT) has emerged as a robust evaluative tool designed to assess clinical reasoning in contexts characterised by uncertainty. By comparing the responses of candidates with ...

Neuropsychiatric disorders need new drugs that offer improvement in safety and efficacy over currently available medicines. Draig Therapeutics has emerged from stealth with $140 million to support mid ...

Kymera Therapeutics has announced that Sanofi will advance their next-generation oral IRAK4 degrader, KT-485, into clinical testing, while opting not to pursue KT-474. Preclinical studies indicated ...